Make Vaccines, Diagnostic Tools, and Treatment for COVID-19 Developed with Public Funding in Australia Available to All

HONOURABLE GREG HUNT, MINISTER FOR HEALTH; HONOURABLE MARISE PAYNE, MINISTER FOR FOREIGN AFFAIRS; HONORABLE KAREN ANDREWS, MINISTER OF INDUSTRY, SCIENCE AND TECHNOLOGY; PROFESSOR PAUL KELLY, ACTING CHIEF MEDICAL OFFICER OF AUSTRALIA

As students, individuals, and organizations who are collectively dedicated to promoting public health and ensuring access to medicines for all, we are concerned about access to diagnostic tools, vaccines, and therapeutics to treat the novel coronavirus disease (COVID-19). Australia has made a significant public investment into "accelerating the development, testing, and implementation of measures to deal with the COVID-19 outbreak”, including developing diagnostic tools, treatments, and vaccines. 

We want to ensure that all diagnostics, vaccines, and treatments for COVID-19 that are developed with Australian public dollars are equitably priced, available to everyone, and free at the point of delivery. We ask for open and non-exclusive licensing to be included as a precondition for receiving funding, for example through the use of Global Access Licensing conditions, and for licensing agreements for any technologies developed with public funds to include clear, transparent, and enforceable requirements for fair and affordable pricing. Equitable access to the end-results of publicly-funded research must be the primary goal of technology transfer.

At the Coronavirus Global Response International Pledging Event, Prime Minister Scott Morrison reminded fellow world leaders of the importance of creating “a safe vaccine, available to all, affordable to all.” For this vision to be realized, the government must ensure that the results of publicly-funded research on COVID-19 are available to all. Protecting the health and well-being of Australians from a highly transmissible disease in a highly interconnected world necessitates a response rooted in global solidarity. At this point, there are more than 4,000,000 cases confirmed in over 180 countries. We must ensure that all people have access to diagnostic tools and vaccines developed in Australia. If monopolies by pharmaceutical corporations inhibit access and availability around the world, Australia’s ability to protect its own residents will be ineffective given that COVID-19 is a global crisis requiring a collective response.

Please consider supporting our letter to the top health officials in Australia who have the power to deliver this funding responsibly. 

Note: If an organization is interested in signing the petition, please email us [email protected] so we can add your name to the list.

 

Sincerely,

Universities Allied for Essential Medicines (UAEM)

Australian Medical Students' Association (AMSA)

 

Who's signing

74 SIGNATURES
500 signatures

Will you sign?